Natoli opens R&D site to study tablet formulation problems

By Fiona BARRY contact

- Last updated on GMT

(Picture credit: Purple Sherbert Photography)
(Picture credit: Purple Sherbert Photography)
The Natoli Engineering Company has opened an pharmaceutical research institute to look for answers to enduring formulation problems in solid oral dosage.

The Natoli Institute for Industrial Pharmacy Research and Development was built at Long Island University, US, in partnership with the Arnold and Marie Schwartz College of Pharmacy and Health Sciences.

The facility features traditional solid dosage formulation equipment, as well as the technology to measure the physical and chemical properties of tablets,​” said Chuck Kettler, Director of Natoli Scientific.

The site has suites for studying formulation, compression, and coating of drugs. Work will concentrate on long-time problems the compression of tablets, the development of formulations for new and existing molecules, and the tablet press measurements needed for proper delivery formulation.  

The laboratory can be used by undergraduate and graduate students looking for solutions to formulation problems, as well as providing resources to the tableting customers. Outsourcing will include studies into tablet disintegration, sticking and picking, bioavailability, and formulation and feasibility.  

Natoli’s pharmaceutical work includes making tools for pill manufacturing, as well as conducting tablet design for clients.

More to follow...

Related news

Show more

Related products

Steridose

Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers